Minimal Residual Disease Market May See a Big Move | Adaptive Biotechnologies, ARUP Laboratories, Bio-Rad Laboratories.,
Increasing consumer preferences for tailored therapies is a major factor driving minimal residual disease market revenue growth
VANCOUVER, BC, CANADA, May 8, 2023 /EINPresswire.com/ -- The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the forecast period, according to the latest analysis by Emergen Research. Rising R&D activities and increase in research funding from various cancer institutes are major factors projected to support market revenue growth between 2021 and 2030. For instance, Invitae Corporation, based in the U.S., started a research in February 2022 to collect actual data on tailored minimal residual disease diagnostics for distinct tumor types. Inivata also introduced RaDaR assay in April 2020 to identify and track residual disease and relapse in plasma samples of patients with prior cancer diagnoses.
The Minimal Residual Disease Market Report study covers global and regional markets with an in-depth analysis of the overall growth prospects of the market. It likewise enlightens the complete serious climate of the worldwide market with an estimated time of 2022-2030. The Minimal Residual Disease Market report provides an additional dashboard overview of key companies covering successful marketing strategies, market contributions, and recent developments in both historical and current situations. Minimal Residual Disease Market Report is high -intensive driven by high R&D investment and has strong product analysis to maintain growth and ensure long-term monetization with a forecast period of 2022-2030.
Download Sample Copy of Minimal Residual Disease Report@ https://www.emergenresearch.com/request-sample/1352
Moreover, the study provides Porter’s five forces model, along with portfolio and financial analysis and business overview of services and products. The report outlines market segmentation and growth analysis of the top 10 market players that are currently active in the Minimal Residual Disease industry. The report also contains information and statistics, tables and figures that are used in strategic planning for the company's success.
Key Players Mentioned in the Minimal Residual Disease Market Research Report:
Adaptive Biotechnologies, ARUP Laboratories, Bio-Rad Laboratories, Inc., Cergentis B.V., F. Hoffmann-La Roche Ltd., ICON Plc, Invivoscribe, Inc., Laboratory Corporation of America Holdings, Mission Bio, Natera, Inc., NeoGenomics Laboratories, OPKO Health, Inc., and Sysmex Corporation.
Some Key Highlights From the Report
The Polymerase Chain Reaction (PCR) segment accounted for a significant revenue share in 2021. PCR examines specific DNA segments for unusual genetic traits. The test increases DNA to make it simpler to identify and count unusual characteristics and blood cells or bone marrow can be used. PCR tests can still detect it, if there is only one cancer cell in a group of 100,000 to 1 million healthy cells.
The hospitals segment accounted for largest revenue share in 2021 owing to availability of various treatment options and frequent patient visits. Hospitals consistently offer services for both acute and complicated diseases, which improves and complements performance of many other parts of the healthcare system.
The North America market accounted for largest revenue share in 2021 owing to increasing prevalence of blood cancer and rising investments from cancer institutions. In addition, rising incidence of hematological cancers in the U.S. is increasing risk of MRD and is expected to drive revenue growth of the market in this region.
Access complete report@ https://www.emergenresearch.com/industry-report/minimal-residual-disease-market
The Minimal Residual Disease market research report delivers a comprehensive analysis of industry size, trends, and business growth prospects. This report also provides detailed information on technology spending for the forecasting period, which gives a unique view of the Minimal Residual Disease market across numerous segments.
Emergen Research has segmented the global minimal residual disease market based on indication, detection, treatment methods, treatment centers, and region:
Indication Outlook (Revenue, USD Million; 2019–2030)
Leukemia
Acute Lymphoblastic Leukemia (ALL)
Chronic Lymphoblastic Leukemia (CLL)
Acute Myeloid Leukemia (AML)
Chronic Myeloid Leukemia (CML)
Others
Lymphoma
Non-Hodgkin’s Lymphoma (NHL)
Marginal Zone Lymphoma
Follicular Lymphoma
Peripheral T-cell Lymphoma
Mantle Cell Lymphoma
Others
Multiple Myeloma (MM)
Solid Tumor
Others
Detection Outlook (Revenue, USD Million; 2019–2030)
Next-Generation Sequencing (NGS)
Flow Cytometry
Polymerase Chain Reaction (PCR)
Fluorescence In-Situ Hybridization (FISH)
Others
Treatment Methods Outlook (Revenue, USD Million; 2019–2030)
Chemotherapy
Stem Cell Transplant
CAR-T Cell Therapy
Others
Treatment Centers Outlook (Revenue, USD Million; 2019–2030)
Hospitals
Oncology Treatment Centers
Diagnostic Centers & Research Institutions
Specialty Clinics
Inquiry for customization or any other related questions at@ https://www.emergenresearch.com/purchase-enquiry/1352
You need to discover how this will impact the Minimal Residual Disease market today, and over the next 10 years:
• Our 250-page report provides 194 tables and 189 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – Now.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you Today how the Minimal Residual Disease market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2030 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Minimal Residual Disease prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company.
Buy a Minimal Residual Disease market report here@ https://www.emergenresearch.com/select-license/1352
Thank you for reading our report. Customization of the report is available according to the requirements of clients. In case of further queries about the report, do get in touch with us. Our team will make sure your report is tailored according to your needs.
Look Over transcripts provided by Emergen Research
impact modifiers market
https://www.emergenresearch.com/industry-report/impact-modifiers-market
artificial intelligence and advanced machine learning market
durable medical equipment market
https://www.emergenresearch.com/industry-report/durable-medical-equipment-market
environmental testing equipment market
https://www.emergenresearch.com/industry-report/environmental-testing-equipment-market
drone package delivery market
https://www.emergenresearch.com/industry-report/drone-package-delivery-market
managed dns service market
https://www.emergenresearch.com/industry-report/managed-dns-service-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
